1Molecular Biology, Genentech, South San Francisco, CA 94080 USA.
2Bioinformatics & Computational Biology, Genentech, South San Francisco, CA 94080 USA.
Commun Biol. 2019 Aug 9;2:304. doi: 10.1038/s42003-019-0551-y. eCollection 2019.
Obtaining full-length antibody heavy- and light-chain variable regions from individual B cells at scale remains a challenging problem. Here we use high-throughput single-cell B-cell receptor sequencing (scBCR-seq) to obtain accurately paired full-length variable regions in a massively parallel fashion. We sequenced more than 250,000 B cells from rat, mouse and human repertoires to characterize their lineages and expansion. In addition, we immunized rats with chicken ovalbumin and profiled antigen-reactive B cells from lymph nodes of immunized animals. The scBCR-seq data recovered 81% ( = 56/69) of B-cell lineages identified from hybridomas generated from the same set of B cells subjected to scBCR-seq. Importantly, scBCR-seq identified an additional 710 candidate lineages not recovered as hybridomas. We synthesized, expressed and tested 93 clones from the identified lineages and found that 99% ( = 92/93) of the clones were antigen-reactive. Our results establish scBCR-seq as a powerful tool for antibody discovery.
从单个 B 细胞中大规模获得全长抗体重链和轻链可变区仍然是一个具有挑战性的问题。在这里,我们使用高通量单细胞 B 细胞受体测序(scBCR-seq)以大规模平行的方式准确地获得配对的全长可变区。我们对来自大鼠、小鼠和人类库的超过 250,000 个 B 细胞进行了测序,以表征它们的谱系和扩增。此外,我们用鸡卵清蛋白免疫大鼠,并对免疫动物淋巴结中的抗原反应性 B 细胞进行了分析。scBCR-seq 数据恢复了从同样的一组 B 细胞进行 scBCR-seq 生成的杂交瘤中鉴定出的 81%(=56/69)B 细胞谱系。重要的是,scBCR-seq 还鉴定出了另外 710 个未被杂交瘤回收的候选谱系。我们从鉴定出的谱系中合成、表达和测试了 93 个克隆,发现 99%(=92/93)的克隆具有抗原反应性。我们的结果确立了 scBCR-seq 作为抗体发现的强大工具。